Your browser doesn't support javascript.
loading
A common SNP in the UNG gene decreases ovarian cancer risk in BRCA2 mutation carriers.
Baquero, Juan Miguel; Benítez-Buelga, Carlos; Fernández, Victoria; Urioste, Miguel; García-Giménez, Jose Luis; Perona, Rosario; Benítez, Javier; Osorio, Ana.
Afiliación
  • Baquero JM; Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Benítez-Buelga C; Helleday Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
  • Fernández V; Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Urioste M; Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.
  • García-Giménez JL; Familial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Perona R; Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.
  • Benítez J; Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.
  • Osorio A; Biomedical Research Institute Alberto Sols (CSIC-UAM), Madrid, Spain.
Mol Oncol ; 13(5): 1110-1120, 2019 05.
Article en En | MEDLINE | ID: mdl-30747491
Single nucleotide polymorphisms (SNPs) in DNA glycosylase genes involved in the base excision repair (BER) pathway can modify breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. We previously found that SNP rs34259 in the uracil-DNA glycosylase gene (UNG) might decrease ovarian cancer risk in BRCA2 mutation carriers. In the present study, we validated this finding in a larger series of familial breast and ovarian cancer patients to gain insights into how this UNG variant exerts its protective effect. We found that rs34259 is associated with significant UNG downregulation and with lower levels of DNA damage at telomeres. In addition, we found that this SNP is associated with significantly lower oxidative stress susceptibility and lower uracil accumulation at telomeres in BRCA2 mutation carriers. Our findings help to explain the association of this variant with a lower cancer risk in BRCA2 mutation carriers and highlight the importance of genetic changes in BER pathway genes as modifiers of cancer susceptibility for BRCA1 and BRCA2 mutation carriers.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Predisposición Genética a la Enfermedad / Polimorfismo de Nucleótido Simple / Proteína BRCA2 / Uracil-ADN Glicosidasa / Mutación Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Predisposición Genética a la Enfermedad / Polimorfismo de Nucleótido Simple / Proteína BRCA2 / Uracil-ADN Glicosidasa / Mutación Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: España
...